Zobrazeno 1 - 10
of 24
pro vyhledávání: '"I. V. Shul'gina"'
Autor:
O. V. Gromova, S. A. Vorob’eva, O. A. Volokh, O. D. Klokova, L. F. Livanova, N. I. Belyakova, E. Z. Popova, O. A. Lobovikova, I. V. Shul’gina, I. G. Shvidenko, A. K. Nikiforov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 164-167 (2023)
The bivalent chemical cholera vaccine is the only drug for the prevention of cholera registered in the Russian Federation. The vaccine has been produced in glass bottles containing 210 tablets. At the same time, modern trends dictate the need to prod
Externí odkaz:
https://doaj.org/article/be24f98798034dc68f288b921715af99
Autor:
A. V. Komissarov, O. A. Lobovikova, I. V. Shul'gina, V. S. Kostyuchenko, E. G. Abramova, O. A. Volokh, N. V. Sinitsyna, V. A. Demchenko, A. S. Fes'kova, A. K. Nikiforov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 3, Pp 115-130 (2021)
Introduction. This publication describes the design and implementation sequence of technological procedures for labeling immunobiological medicinal products produced by the FGHI RusRAPI "Microbe" of the Rospotrebnadzor. In light of meeting the requir
Externí odkaz:
https://doaj.org/article/4c1d0f48d1944f2e8f5b2627508659ca
Autor:
O. A. Lobovikova, I. V. Shul'gina, E. G. Abramova, A. K. Nikiforov, A. V. Komissarov, V. A. Demchenko, A. G. Selezneva, A. S. Fes'kova, S. S. Galetova, N. P. Mironova
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 8, Iss 1, Pp 92-96 (2019)
Introduction. Documentation is an integral part of the quality management system, a key element of production and quality control of medicines. A necessary condition for the Rules of good manufacturing practice and guaranteed production of quality pr
Externí odkaz:
https://doaj.org/article/e2b5b9429fef4aabbb3d8f14e5d50811
Autor:
E. G. Abramova, O. A. Lobovikova, I. V. Shul’gina, A. V. Komissarov, L. V. Savitskaya, S. V. Generalov, M. V. Galkina, Yu. K. Gavrilova, A. V. Kochkin, A. K. Nikiforov
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 0, Iss 4, Pp 160-164 (2019)
The paper contains the data on the development of quality control sample (QCS) for determination of specific activity of heterologous anti-rabies immunoglobulin in neutralization test on white mice. Given are the results on QCS attestation in referen
Externí odkaz:
https://doaj.org/article/5dc205990edb42dbba03bc0335b0a29e
Autor:
I. V. Novitskaya, E. V. Prokhvatilova, A. V. Toporkov, D. V. Viktorov, M. Ya. Kulakov, E. V. Savina, V. G. Pushkar’, L. I. Belitskaya, N. A. Osina, Zh. A. Kas’yan, I. V. Shul’gina, O. A. Lobovikova
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 75-79 (2017)
Objective of the study was to assess analytical and diagnostic sensitivity and specificity of the “Reagent kit. Erythrocytic coccidioidomycosal and histoplasmosal immunoglobulin dry diagnosticum”, designed for identification of causative agents o
Externí odkaz:
https://doaj.org/article/d0350cf9b07d4ed0a9f379f6ef2e01f2
Autor:
Z. L. Devdariani, N. A. Syrova, E. A. Mikheeva, I. V. Terekhova, N. M. Ermakov, G. V. Grigor’eva, O. A. Lobovikova, I. V. Shul’gina
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3, Pp 85-89 (2016)
Objective of the study was to develop and then conduct medical trials of the “Monoclonal immune-enzyme test-system for the detection of plague agent (“EIAPESTF1-M”).Materials and methods. Utilized were materials for carrying out sandwich EIA. M
Externí odkaz:
https://doaj.org/article/0b0dd8736662446489b534ad51e8c1b2
Autor:
A. V. Komissarov, A. Yu. Ul’Yanov, O. A. Volokh, I. V. Shul’Gina, O. A. Lobovikova, O. D. Klokova, A. K. Nikiforov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 94-96 (2016)
Objective of the study is to experimentally substantiate the possibility to improve manufacturing efficiency by means of mass reduction of a vaccine tablet from 300 to 100 mg. Materials and methods. Inaba O-antigen lyophilizate serves as the specific
Externí odkaz:
https://doaj.org/article/c9faf1f9327642089b3d744dc26f45a9
Autor:
N. E. Tereshkina, I. V. Terekhova, N. A. Syrova, Z. L. Devdariani, O. Yu. Lyashova, G. V. Grigor’Eva, O. A. Lobovikova, I. V. Shul’Gina, I. L. Ivanenko, N. B. Zakharova, G. A. Bezrukova, V. F. Spirin
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 2, Pp 42-45 (2013)
mc/ml. Additionally, this test-system has been proving for acquisition of sustainable results after 6 months of storing (the observation period). Medical trials of the panel of reagents “Monoclonal dot-immuno-enzyme test-system for tularemia microb
Externí odkaz:
https://doaj.org/article/fbe9ca0edba3493086da0c3a43362ab0
Autor:
T. V. Alenkina, G. V. Bochkareva, L. V. Sayapina, I. V. Kasina, I. V. Shul’Gina, O. A. Lobovikova, E. G. Abramova, O. V. Gromova, A. K. Nikiforov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 3(113), Pp 74-78 (2012)
– for environmental objects. Application of the preparation for practical purposes was considered to be promising, and it was recommended for State registration as a product of medical application.
Externí odkaz:
https://doaj.org/article/1dd42819247e4f8d8a4041e2a2167a2e
Autor:
I. M. Zhulidov, E. G. Abramova, A. K. Nikiforov, M. V. Antonycheva, I. V. Shul'gina, O. A. Lobovikova, N. I. Vakhrushina, A. D. Belousov, S. A. Eremin, M. N. Kireev, N. A. Sharapova, L. V. Savitskaya, T. A. Mikheeva, L. N. Minaeva, M. V. Galkina, R. A. Svintsov, T. V. Alenkina, Yu. G. Vasin, G. V. Bazlov
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4(110), Pp 80-84 (2011)
Presented is a comprehensive approach to utilization of the wastes that appear in the process of heterologous anti-rabies immunoglobulin production (packed red cells, fibrin, and alcohol-containing products). Specific immunoglobulin is extracted from
Externí odkaz:
https://doaj.org/article/9b075e54337f44f89187f79f921a8c96